CAS: 35700-40-4; 2,3-Dihydrobenzofuran-7-Carboxylic Acid

该化合物是有机化合物,具有独特的双环结构,结合了苯丙胺和碳酸的功能,具有芳香化合物的特性,例如稳定性和各种化学反应的可能性,包括电益替代,这种化合物的出现具有酸性,允许其参与酸基反应,并有可能成为进一步化学合成的前体.二氢苯甲酸在极地溶剂中也可能表现出溶性,因为其芳香性质会影响其与非极地溶剂的相互作用.此外,这种化合物可能在制药,农用化学品或有机合成中具有应用性,但具体应用将取决于其反应性和使用环境.与许多有机化合物一样,在与该物质打交道时,应当考虑安全数据和处理预防措施.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号496-16-2 2,3-二氢苯并呋喃 | CAS号124-38-9 二氧化碳 | CAS号110-18-9 四甲基乙二胺(TEMED) | CAS号75934-15-5 7-(Oxazolinyl)d... | CAS号119-36-8 水杨酸甲酯 | CAS号133844-95-8 2,3-二氢苯并呋喃-7-羧酸甲酯 | CAS号13661-90-0 2-vinyloxy-benz... | CAS号75855-24-2 methyl 2-hydrox... | CAS号69-72-7 水杨酸 | CAS号6282-42-4 methyl 2-prop-2... | CAS号108551-60-6 5-溴-2,3-二氢苯并[B]... | CAS号90484-22-3 苯并呋喃-7-羧酸 | CAS号41177-72-4 5-溴-2,3-二氢苯并呋喃-7-羧酸 | CAS号133844-95-8 2,3-二氢苯并呋喃-7-羧酸甲酯 | CAS号13414-56-7 7-氨基-2,3-二氢苯并呋喃 | CAS号170730-06-0 7-乙酰基-2,3-二氢苯并呋喃 | CAS号151155-53-2 2,3-二氢苯并呋喃-7-甲醇 | CAS号123266-63-7 2,3-二氢-1-苯并呋喃-7-碳酰氯 | CAS号920739-80-6 5-amino-2,3-dih... | CAS号98205-73-3 1-(2,3-dihydro-...

合成工艺路线路线简述

    3-烯丙基-2-羟基苯甲酸甲酯置于盐酸,Sodium Hydroxide,Sodium Tetrahydroborate,氯化亚砜,二甲基硫,Sodium Hydride,臭氧体系中,用 四氢呋喃,乙醇,水 用作溶剂,化学反应 64.5H,反应生成2,3-二氢苯并呋喃-7-羧酸
    参考文献:Nucleophilic Annulations Of Aromatics. Novel Route To Benzo-Fused Ring Systems Via Oxazoline Activation
    标题:Nucleophilic Annulations Of Aromatics. Novel Route To Benzo-Fused Ring Systems Via Oxazoline Activation
    摘要:
    Doi:10.1021/jo00317A027

    海关参考信息

    专利信息


    专利号:US-2025092004-A1
    优先权日:2022-01-14
    标题:Method for producing intermediate useful for synethesis of sglt inhibitor
    发明人:YOON HEE KYOON; YOON YOUN JUNG
    权利人:DAEWOONG PHARMACEUTICAL CO LTD
    摘要:The present invention relates to a method for producing an intermediate useful for the synthesis of an SGLT inhibitor. According to the present invention, a compound of Chemical Formula 9, which is an important intermediate for a compound of Chemical Formula 1 as an SGTL inhibitor, may be obtained with high yield and high quality. A method for producing the SGLT inhibitor according to the present invention enables production without special facilities such as an ozone generator and thus is also much more economical.

    专利号:US-8748459-B2
    优先权日:2002-03-29
    标 题 :Pyridinoylpiperidines as 5-HT1F agonists
    发明人:COHEN MICHAEL PHILIP; KOHLMAN DANIEL TIMOTHY; LIANG SIDNEY XI; VICTOR FRANTZ; XU YAO-CHANG; YING BAI-PING; ZACHERL DEANNA PIATT; ZHANG DEYI
    权利人:COHEN MICHAEL PHILIP; KOHLMAN DANIEL TIMOTHY; LIANG SIDNEY XI; VICTOR FRANTZ; XU YAO-CHANG; YING BAI-PING; ZACHERL DEANNA PIATT; ZHANG DEYI; LILLY CO ELI
    摘要:The present invention relates to compounds of formula I: n nor pharmaceutically acceptable acid addition salts thereof, where;n R 1 is C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 3 -C 7 cycloalkyl, substituted C 3 -C 7 cycloalkyl, C 3 -C 7 cycloalkyl-C 1 -C 3 alkyl, substituted C 3 -C 7 cycloalkyl-C 1 -C 3 alkyl, phenyl, substituted phenyl, heterocycle, or substituted heterocycle; R 2 is hydrogen, C 1 -C 3 alkyl, C 3 -C 6 cycloalkyl-C 1 -C 3 alkyl, or a group of formula II nn n n n n n n n n n n n R 3 is hydrogen or C 1 -C 3 alkyl; n R 4 is hydrogen, halo, or C 1 -C 3 alkyl; n R 5 is hydrogen or C 1 -C 3 alkyl; n R 6 is hydrogen or C 1 -C 6 alkyl; and n n is an integer from 1 to 6 inclusively. n n n n n The compounds of the present invention are useful for activating 5-HT lF receptors, inhibiting neuronal protein extravasation, and for the treatment or prevention of migraine in a mammal. The present invention also relates to a process for the synthesis of intermediates in the synthesis of compounds of Formula I.

    专利号:CN-117550990-A
    优先权日:2018-05-25
    标 题 :Process for the synthesis of (S) -3-amino-4- (difluoromethylene) cyclopent-1-ene-1-carboxylic acid

    专利号:TW-202340162-A
    优先权日:2022-01-14
    标 题 :A method of preparing intermediates useful for the synthesis of sglt inhibitors

    专利号:CN-112513006-B
    优先权日:2018-05-25
    标 题 :Process for the synthesis of (S) -3-amino-4- (difluoromethylene) cyclopent-1-ene-1-carboxylic acid

    专利号:CN-117550991-A
    优先权日:2018-05-25
    标 题:Process for the synthesis of (S) -3-amino-4- (difluoromethylene) cyclopent-1-ene-1-carboxylic acid
    宁波英特格瑞生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.integrity-bio.com
    企业联系电话:0574-86822786👤
    📞宁波英特格瑞生物科技有限公司 ⚠️参考联系方式
    联系人:石经理
    电话:0574-86822786
    手机:15824278467
    传真:0574-86821822
    邮箱:sales@integrity-bio.com
    通信地址: 宁波北仑区明州路731号长江国际A座1209室
    邮编: 315000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:宁波北仑区明州路731号长江国际A座1209室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/bf00808952
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知